SAB Biotherapeutics, Inc. (SABS)

Price & Market Data

Price: $3.57

Daily Change: -$0.153 / 4.29%

Daily Range: $3.55 - $3.80

Market Cap: $254,398,064

Daily Volume: 836,979

Performance Metrics

1 Week: -1.63%

1 Month: -7.18%

3 Months: -13.40%

6 Months: 13.12%

1 Year: 82.83%

YTD: -3.21%

About SAB Biotherapeutics, Inc. (SABS)

Stay informed about SAB Biotherapeutics, Inc. (SABS). Price: 3.57, daily change: -$0.153 / 4.29%. Market cap: 254,398,064. Detailed performance for all key periods.

Company Details

Employees: 86

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes in Phase 2b clinical trials. The company was founded in 2014 and is headquartered in Miami Beach, Florida.

Selected stocks

Fenbo Holdings Limited (FEBO)

CuriosityStream Inc. (CURI)

i-80 Gold Corp. (IAUX)

Ichor Holdings (ICHR)

South Plains Financial, Inc. (SPFI)